The Effects of High-intensity and Moderate-intensity Exercise on Polycystic Ovary Syndrome
The Effects of High- and Moderate-Intensity Exercise on the Cerebrovascular and Cardiometabolic Health of Women With Polycystic Ovary Syndrome
1 other identifier
interventional
34
1 country
1
Brief Summary
This study will investigate the impact of high- and moderate-intensity exercise on the cardiometabolic and brain health of women with Polycystic Ovary syndrome (PCOS). The aim is to measure and compare normal, healthy women without PCOS, to those with the condition. All participants will undergo a blood test. The investigators will then assess the participants cardiovascular fitness by means of a maximal exercise test and measure body composition through height, weight, and hip-to-waist ratio. Participants will undergo an MRI, where the investigators will assess the participants brain structure and how the brain responds to a number of tests. The investigators will also conduct some tests that will assess the participants cognition, such as IQ, memory etc. The investigators will measure the blood vessels leading to the brain and the blood flow through them to measure how much blood the brain receives when rested, using ultrasound. The investigators will use a number of tests to look at brain function, measure the responses to these tests, and compare them between the normal, healthy women and those with PCOS. This will show if women with PCOS have a similar brain function when rested and when their brains are tested to those without the condition. The investigators will use exercise as an intervention, where the aim will be to investigate whether women with PCOS respond similarly to those without the condition to both high-intensity and moderate-intensity exercise. The tests of brain function will be repeated following the exercise, and see if both normal, healthy women and those with PCOS have a similar response to the brain function tests. All tests and measures will be compared between the PCOS group, and the healthy control group to establish any potential differences or similarities as a result of the condition.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2020
CompletedFirst Submitted
Initial submission to the registry
February 10, 2022
CompletedFirst Posted
Study publicly available on registry
May 27, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 25, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 25, 2024
CompletedFebruary 13, 2025
February 1, 2025
4.4 years
February 10, 2022
February 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Cerebrovascular Reactivity to Carbon Dioxide (CO2)
6% CO2 administered to measure reactivity of the cerebrovasculature as measured by extra-cranial ultrasonography.
Baseline
Cerebrovascular Reactivity to Carbon Dioxide (CO2)
6% CO2 administered to measure reactivity of the cerebrovasculature as measured by extra-cranial ultrasonography.
Less than 1 hour post-exercise
Neurovascular coupling (NVC)
NVC will be assessed using a visual task (flashing checkerboard) measured via transcranial Doppler.
Baseline
Neurovascular coupling (NVC)
NVC will be assessed using a visual task (flashing checkerboard) measured via transcranial Doppler.
Less than 1 hour post-exercise
Dynamic cerebral autoregulation (dCA)
dCA will be assessed using a squat-stand method to induce forced oscillations in blood pressure and measured using finger plethysmography and transcranial Doppler.
Baseline
Dynamic cerebral autoregulation (dCA)
dCA will be assessed using a squat-stand method to induce forced oscillations in blood pressure and measured using finger plethysmography and transcranial Doppler.
Less than 1 hour post-exercise
Cerebral blood velocity in the middle (MCAv) and posterior cerebral arteries (PCAv) during exercise
MCAv and PCAv will be assessed using transcranial Doppler and employed throughout both bouts of acute exercise.
During high-intensity exercise (24 minutes)
Cerebral blood velocity in the middle (MCAv) and posterior cerebral arteries (PCAv) during exercise
MCAv and PCAv will be assessed using transcranial Doppler and employed throughout both bouts of acute exercise.
During moderate-intensity exercise (50 minutes)
Secondary Outcomes (10)
Cardiorespiratory fitness (CRF)
Baseline
Cerebral structure
Baseline
Cerebral blood flow
Baseline
Cerebral metabolic rate of oxygen consumption
Baseline
Cerebrovascular reactivity
Baseline
- +5 more secondary outcomes
Study Arms (2)
Polycystic Ovary Syndrome
EXPERIMENTALWomen with PCOS
Controls
ACTIVE COMPARATORHealthy, age and BMI matched controls
Interventions
Acute, low-volume HIIT 12x (1min:1min) Working intensity: \>85% heart rate reserve Resting intensity: Active rest
Continuous, MISS 50mins Working intensity: 50-60% heart rate reserve
Eligibility Criteria
You may qualify if:
- Polycystic Ovary Syndrome as diagnosed by any recognised criteria.
- Inactive (less than 40 mins of structured exercise per week).
You may not qualify if:
- Pregnant or breastfeeding.
- Congenital adrenal hyperplasia, Cushing's syndrome, thyroid disease, hyperprolactinaemia and androgen secreting tumours.
- Known history of cardiovascular disease.
- Contraindications to MRI (fitted with ferromagnetic devices).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cardiff Metropolitan Universitylead
- Cardiff Universitycollaborator
Study Sites (1)
Cardiff Metropolitan University
Cardiff, CF242SX, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- All participant data and exercise arm will be anonymised and non-identifiable by the assessor.
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 10, 2022
First Posted
May 27, 2022
Study Start
January 1, 2020
Primary Completion
May 25, 2024
Study Completion
May 25, 2024
Last Updated
February 13, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- ANALYTIC CODE
- Time Frame
- January 2024 - 5 years
Applications for access to study- and participant-level data will be considered on direct enquiry.